Therapeutically Targeting MicroRNAs in Liver Cancer
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
1180-1191
Author(s):
Alexandra Drakaki, Maria Hatziapostolou and Dimitrios Iliopoulos
The Role of microRNAs in the Pathogenesis and Treatment of Hematopoietic Malignancies
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
1201-1210
Author(s):
Corina A. Schmid, Vanessa J. Craig, Anne Muller and Michael Flori
MicroRNAs (miRNAs) in Colorectal Cancer: From Aberrant Expression Towards Therapy
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
1242-1252
Author(s):
Hannelore Dassow and Achim Aigner
The Expression Patterns and Clinical Significance of microRNAs in Liver Diseases and Hepatocellular Carcinoma
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
1262-1272
Author(s):
Jinsheng Guo and Scott L. Friedman
miRNAs in Gastrointestinal and Liver Cancers: Their Perspectives and Clinical Applications
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
1301-1310
Author(s):
Jing Shen, William K.K. Wu, Shun X. Ren, Lin Zhang, Ruby L.Y. Chan, Clover C.M.Wong, Lan Lu and Chi H. Cho
Substance-Related Disorders and Somatic Symptoms: How Should Clinicians Understand the Associations?
Journal:
Current Drug Abuse Reviews
Volume:
5
Page:
291-303
Author(s):
Kouichi Yoshimasu
Viral Proteases as Targets for Drug Design
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
1126-1153
Author(s):
Marcin Skorenski and Marcin Sienczyk
Functional Evaluation of Imatinib mesylate in Hepatocellular Carcinoma Cells
Journal:
Recent Patents on Biomarkers
Volume:
3
Page:
65-71
Author(s):
Mai A. Saad Zaghloul, Ashraf H. Abadi and Ahmed I. Abdelaziz
Patent Selections
Journal:
Recent Patents on Biomarkers
Volume:
3
Page:
79-80
Author(s):
Novel Agents Targeting Bioactive Sphingolipids for the Treatment of Cancer
Journal:
Current Medicinal Chemistry
Volume:
20
Page:
108-122
Author(s):
A. Adan-Gokbulut, M. Kartal-Yandim, G. Iskender and Y. Baran